Search

everythinglearnresearchcommunity

for

Search:↓

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

Botanical lotion CG428 may help regrow hair and reduce scalp inflammation in chemotherapy patients.

REVIVV® serum improves hair growth and reduces shedding in androgenetic alopecia.

The Chromolaena odorata patch significantly speeds up wound healing.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

A reliable method was developed to ensure hair growth products have the right amount of active ingredients.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

New hybrid compound found to effectively prevent hair loss.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Wedelolactone may help reduce bone loss with fewer side effects.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Repurposing existing drugs can quickly and cheaply find new treatments for diseases.

People often struggle to consistently use contraceptives and other medications, and long-acting options might be better for those who want to avoid daily doses.

Low-dose oral minoxidil for hair loss seems to have rare side effects, but more research is needed to confirm its safety.

A rare lupus case on the chin was successfully treated with steroids and immunomodulators after accurate diagnosis using advanced imaging techniques.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Pharmacists play a crucial role in health literacy and patient care.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Physcion may help treat hair loss by blocking an enzyme linked to baldness.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.